We are live on ! Find out more
FC

Fulcrum Capital Portfolio holdings

AUM $493M
1-Year Est. Return 24.43%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+24.43%
3 Year Est. Return
+83.4%
5 Year Est. Return
+102.6%
10 Year Est. Return
AUM
$387M
AUM Growth
+$42.2M
Cap. Flow
-$1.68M
Cap. Flow %
-0.43%
Top 10 Hldgs %
44.13%
Holding
123
New
14
Increased
16
Reduced
48
Closed
4

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$8.91M
2
BLK icon
Blackrock
BLK
+$4.66M
3
HSY icon
Hershey
HSY
+$1.87M
4
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$1.83M
5
EW icon
Edwards Lifesciences
EW
+$1.33M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$4.65M
2
NVDA icon
NVIDIA
NVDA
+$4.64M
3
MSFT icon
Microsoft
MSFT
+$2.21M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$2.07M
5
AAPL icon
Apple
AAPL
+$2.07M

Sector Composition

Rank Sector Weight
1 Technology 22.68%
2 Financials 13.42%
3 Healthcare 12.95%
4 Consumer Discretionary 9.22%
5 Communication Services 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSLR icon
26
First Solar
FSLR
$25B
$5.74M 1.48%
33,327
+6,039
+22% +$924K
LIN icon
27
Linde
LIN
$222B
$5.57M 1.44%
13,557
-202
-1% -$79.7K
BLK icon
28
Blackrock
BLK
$175B
$5.42M 1.4%
+6,673
New +$4.66M
EA icon
29
Electronic Arts
EA
$53B
$5.41M 1.4%
39,560
-1,615
-4% -$213K
EOG icon
30
EOG Resources
EOG
$77.6B
$5.25M 1.36%
43,436
+3,983
+10% +$496K
PXD
31
DELISTED
Pioneer Natural Resource Co.
PXD
$5.09M 1.32%
22,622
+777
+4% +$182K
ABT icon
32
Abbott
ABT
$185B
$4.45M 1.15%
40,402
+2,557
+7% +$255K
XBI icon
33
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$4.12M 1.06%
46,098
+313
+0.7% +$23.2K
PYPL icon
34
PayPal
PYPL
$49.5B
$3.96M 1.02%
64,431
-1,291
-2% -$74K
BBY icon
35
Best Buy
BBY
$18B
$2.97M 0.77%
37,937
-2,499
-6% -$176K
TSLA icon
36
Tesla
TSLA
$1.27T
$2.82M 0.73%
11,339
-1,840
-14% -$437K
AMGN icon
37
Amgen
AMGN
$204B
$2.72M 0.7%
9,438
-3,043
-24% -$829K
WST icon
38
West Pharmaceutical
WST
$24.5B
$2.42M 0.63%
6,878
+330
+5% +$117K
ALGN icon
39
Align Technology
ALGN
$12.4B
$2.2M 0.57%
8,015
+1,573
+24% +$373K
HUM icon
40
Humana
HUM
$45B
$1.95M 0.51%
4,267
-1,345
-24% -$663K
IWR icon
41
iShares Russell Mid-Cap ETF
IWR
$56.3B
$1.8M 0.47%
23,209
-4,170
-15% -$296K
V icon
42
Visa
V
$683B
$1.56M 0.4%
6,000
-72
-1% -$17.7K
GOOG icon
43
Alphabet (Google) Class C
GOOG
$4.56T
$1.36M 0.35%
9,677
-269
-3% -$36.5K
IEFA icon
44
iShares Core MSCI EAFE ETF
IEFA
$191B
$1.34M 0.35%
18,986
-13,485
-42% -$889K
ECL icon
45
Ecolab
ECL
$78.6B
$1.34M 0.35%
6,731
-2,178
-24% -$392K
COST icon
46
Costco
COST
$423B
$1.28M 0.33%
1,941
-200
-9% -$119K
VYM icon
47
Vanguard High Dividend Yield ETF
VYM
$81.4B
$1.2M 0.31%
10,765
XLV icon
48
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$1.19M 0.31%
8,732
VZ icon
49
Verizon
VZ
$198B
$1.03M 0.27%
27,242
-6,645
-20% -$235K
BRK.B icon
50
Berkshire Hathaway Class B
BRK.B
$1.11T
$988K 0.26%
2,770

Similar funds

Fulcrum Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Fulcrum Capital held 123 positions worth $387M, up 12% from $344M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fulcrum Capital's Q4 2023 filing shows 14 new, 16 increased, 48 reduced and 4 closed positions. Its largest new stake was UnitedHealth: 16,697 shares worth $8.79M. The largest sale was Adobe, an estimated $4.65M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Fulcrum Capital's largest Q4 2023 buy was UnitedHealth: 16,697 shares worth $8.79M.
  • Fulcrum Capital added most to Hershey in Q4 2023, an estimated $1.87M increase.
  • Fulcrum Capital's biggest Q4 2023 reduction was Adobe, cutting an estimated $4.65M.
  • Fulcrum Capital fully exited iShares MSCI Emerging Markets ETF in Q4 2023, selling an estimated $2.07M.
  • Fulcrum Capital's ten largest holdings make up 44% of its $387M portfolio in Q4 2023.
  • Fulcrum Capital opened 14 new positions and closed 4 in Q4 2023.
  • Fulcrum Capital's portfolio value rose 12% quarter-over-quarter to $387M.

Based on Fulcrum Capital's 13F filing for Q4 2023, filed 10 Jan 2024.